Showing results (661-670 of 916) with videos related to

Sort By:
Pageof 92
Disability and Rehabilitation|November 14, 2008
Novel methods for tendon investigationsM Kjaer, H Langberg, J Bojsen-Møller, et al.
Frontiers in Cell and Developmental Biology|August 16, 2021
CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab VedotinLiudmila Lobastova, Marcus Lettau, Felix Babatz, et al.
Cells|December 11, 2022
Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic CancerEmilie A Madsen, Jeppe Thorlacius-Ussing, Neel I Nissen, et al.
Molecular Cancer Therapeutics|November 18, 2003
Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3James D Anderson, Todd P Hansen, Paul W Lenkowski, et al.
Scandinavian Journal of Immunology|July 9, 2020
Preoperative TruCulture® whole blood cytokine response predicts post-operative inflammation in pancreaticoduodenectomy patients-A pilot cohort studyEske K Aasvang, Sandra Pitter, Carsten P Hansen, et al.
Discovery Immunology|June 21, 2024
IL-21 conditions antigen-presenting human γδ T-cells to promote IL-10 expression in naïve and memory CD4+ T-cellsChristopher J Tyler, Inva Hoti, Daniel D Griffiths, et al.
Transplantation|January 23, 2026
Serial Assessment of Cardiac Mitochondrial Function in the Early Phase After Heart TransplantationKatrine B Okholm, Jacob M Seefeldt, Frederik F Dalsgaard, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2019
Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal DiseaseMorten B Jørgensen, Thomas Idorn, Casper Rydahl, et al.
Frontiers in Molecular Biosciences|March 27, 2023
High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinomaNeel I Nissen, Astrid Z Johansen, Inna M Chen, et al.
BMC Cancer|May 20, 2025
Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinomaRasmus S Pedersen, Annika Hettich, Jeppe Thorlacius-Ussing, et al.
Pageof 92